Rally #188-1-6082
BD #256082
BD Veritor™ Plus System SARS-CoV-2 Kit (30 Test/KT)
Respiratory Test Kit, SARS-COV-2, Rapid Chromatographic Digital Immunoassay, Anterior Nasal Swab, Rx Only
BD Veritor™ Mix & Match Promotional Offerings
Save On BD Veritor™ Rapid Antigen Tests!Buy 4 BD Kits Of Any Combination, Get 1 at No Additional Cost
(1 Kit = 30 Tests)
Offer Valid Through March 31, 2025
See Details Below
- Helps reduce manual test processing errors with its easy operation and single-button functionality
- Provides intuitive sample processing with prefilled, unitized tubes
- Displays easy-to-read digital results for COVID-19 in 15 minutes
- Provides clear, objective results by correcting for nonspecific binding and detecting positives not recognized by the unaided eye
- Adapts easily to your workflow by offering 2 operational modes: Walk Away and Analyze Now
- Stores or downloads the lot number, patient/specimen ID, operator ID and test records using the BD Veritor™ InfoWiFi module or via the companion ImageMover application
- Offers result printing capabilities via USB port
This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 does not differentiate between SARS-CoV and SARS-CoV-2. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen, which is generally detectable in anterior nasal swab specimens during the acute phase of infection.
All negative results are presumptive and confirmation with a molecular assay, if necessary for patient management, may be performed. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions.
Important Note:
- Product is non-returnable; please make sure it is the right product before ordering.
- If put into refrigeration, do not freeze.
- For in vitro diagnostic use.
- Test kits is intended for use with the analyzer.
- For use under an Emergency Use Authorization (EUA) only.
- For more information on this product's EUA, please go to the EUA section below.
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.
×
| Rally # | 188-1-6082 |
| Manufacturer # | 256082 |
| GTIN | 00382902560821 |
| Brand | BD Veritor™ System |
| Manufacturer | BD |
| Country of Origin | Unknown |
| Application | Respiratory Test Kit |
| For Use With | For use with the BD Veritor™ Plus Analyzer running Firmware version 5.4 or later |
| Number of Tests | 30 Tests |
| Reading Type | Machine Read |
| Sample Type | Anterior Nasal Swab Sample |
| Specialty | Immunoassay |
| Test Format | Test Device Format |
| Test Kit Type | Rapid |
| Test Method | Chromatographic Digital Immunoassay |
| Test Name | SARS-CoV-2 |
| Time to Results | 15 Minute Results |
| UNSPSC Code | 41116144 |
| Storage Temperature | 2-30 °C (Do not Freeze) |
| Shelf Life (Days) | 300 |
| Type | PPA | NPA | Results In |
| COVID-19 (SARS-CoV-2) | 84% (95% CI, 67%-93%) |
100% (95% CI, 98%-100%) |
15 minutes |
PPA = positive percent agreement
NPA = negative percent agreement
×
Configurations
Configurations
| Product ID | Description | Unit of Measure |
| 256066 | BD Veritor™ Plus Analyzer | 1/EA |
| 256082 | BD Veritor™ Plus System SARS-CoV-2 Kit | 30 Tests/Kit |
| 256084 | Combo Veritor Plus SARS-COV-2 KIT (2 Kits of 256082 + 1 of 256066 Analyzer) | 1 Kit |
×
BD Veritor™ for SARS-CoV-2 Kit - 256082 Contents:
BD Veritor™ for SARS-CoV-2 Kit - 256082 Contents:
| Kit Component | Quantity | Description |
| BD Veritor™ System Test Devices | 30 single use test devices | Foil pouched test device containing one reactive strip. Each strip has one line of murine anti-SARS coronavirus monoclonal antibody on the test line, and one of biotin coupled to bovine protein on the positive control line. Murine and Leporine anti-SARS coronavirus and anti-biotin monoclonal antibodies conjugated to detector reagents are bound in the sample delivery area. |
| Extraction Reagent | 30 single use reaction tubes, each with 325 µL extraction reagent and having an integral dispensing tip | Detergent solution with less than 0.1% sodium azide (preservative). |
| Specimen Sampling Swabs | 30 sterile, single use specimen sampling swabs | For sample collection and transfer. |
| SARS-CoV-2 (+) Control Swab | 1 each – individually wrapped for single use | Non-infectious, recombinant viral protein antigen with less than 0.1% sodium azide. |
| SARS-CoV-2 (–) Control Swab | 1 each – individually wrapped for single use | Buffer with less than 0.1% sodium azide. |
| Assay Documentation |
1 each – Instructions for use 1 each – Quick reference instruction card 1 each – Nasal sampling instructions |
|
×
Documentation Links
Documentation Links
- BD Veritor™ SARS-CoV-2 Sell Sheet
- BD Veritor™ SARS-CoV-2 Emergency Use Authorization (EUA) letter
- BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Instructions for Use
- BD Veritor™ Plus System SARS-CoV-2 Assay Fact Sheet for Healthcare Providers
- BD Veritor™ Plus System SARS-CoV-2 Assay Fact Sheet for Patients
- Quick Reference Instructions for BD Veritor™ Plus System SARS-CoV-2
- BD Veritor™ Plus Analyzer - Instructions for Use
×
Video Links
Video Links
- Rapid COVID-19 & Influenza testing
- Rapid COVID-19 testing
- Understanding Point-of-Care Testing
- Point-of-Care Testing with BD Veritor™
- BD Veritor™ Plus System - COVID-19 and Flu A+B Testing
- BD Veritor™ Plus System - Performing COVID-19 Testing
- BD Veritor™ Plus System - Reporting Your Results
- BD Veritor™ Plus System - Keys to Successful Testing
- Understanding your results with BD Veritor™
- Batch testing with the BD Veritor System for SARS-CoV-2
- BD Veritor™ System Set up and use
- BD Veritor™ System - Sample collection
- BD Veritor™ System Sample processing - Analyze Now mode
- BD Veritor™ System Sample processing - Walk Away mode
- BD Veritor Plus System for Rapid Detection of SARS CoV 2
- BD Veritor™ Plus Analyzer - optional modules
- BD Veritor™ Plus Analyzer - data download workflow
- BD Veritor™ Plus Analyzer - printing
- BD Veritor™ Plus Analyzer - overview
- The BD Veritor™ System + the Image Mover app
×
BD Veritor™ Mix & Match Promotional Offer
Save on BD Veritor™ rapid antigen tests!
Buy 4 kits, get 1 at no additional cost.
(1 Kit = 30 Tests)
Mix & Match: Promotional offerings available in any combination (below).
Offer valid through March 31, 2025 Only.
Promotional Items
Note: Offer excludes Group A Strep kits and RSV Moderate Complexity kits.
To receive your promotional item(s), customers will need to complete a form provided by BD, and upload the proof of purchase.
The customer will receive a Proof of Purchase from Rally Inc. after purchasing the product. However, the promotional offer is handled solely between you, the customer, and the manufacturer, BD (Becton, Dickinson and Company). Rally Inc. does not oversee these offers. To check eligibility for the promotion and receive your promotional item, please follow the manufacturer's online instructions.
Note: Some items are under Emergency Use Authorization, please check their EUA before purchasing.
You can find more informations on this product's promotion and the required form here.
BD Veritor™ Mix & Match Promotional Offer
Save on BD Veritor™ rapid antigen tests!Buy 4 kits, get 1 at no additional cost.
(1 Kit = 30 Tests)
Mix & Match: Promotional offerings available in any combination (below).
Offer valid through March 31, 2025 Only.
Promotional Items
| BD Item Number | Description |
| 256088 | BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 & Influenza A+B |
| 256082 | BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 |
| 256045 | BD Veritor™ Plus System for Rapid Detection of Influenza A+B CLIA-Waived |
| 256041 | BD Veritor™ Plus System for Rapid Detection of Influenza A+B (moderate complexity) |
| 256038 | BD Veritor™ Plus System for Rapid Detection of Respiratory Syncytial Virus (RSV) CLIA-Waived |
Note: Offer excludes Group A Strep kits and RSV Moderate Complexity kits.
To receive your promotional item(s), customers will need to complete a form provided by BD, and upload the proof of purchase.
The customer will receive a Proof of Purchase from Rally Inc. after purchasing the product. However, the promotional offer is handled solely between you, the customer, and the manufacturer, BD (Becton, Dickinson and Company). Rally Inc. does not oversee these offers. To check eligibility for the promotion and receive your promotional item, please follow the manufacturer's online instructions.
Note: Some items are under Emergency Use Authorization, please check their EUA before purchasing.
You can find more informations on this product's promotion and the required form here.
×
You can find more informations on reimbursement details here.
- Reimbursements Information -
This product maybe reimbursable, depending on various factors including current law and policies. Rally Inc. does not handle these reimbursements; instead, each reimbursement is handled solely between you, the customer, and the manufacturer, BD. Rally Inc. does not oversee these reimbursements. To check eligibility and get your reimbursements, please follow the manufacturer's reimbursements instructions.You can find more informations on reimbursement details here.
×
This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
EUA - Emergency Use Authorization
In the USA, this product has not been FDA cleared or approved; but has been authorized by FDA under an Emergency Use Authorization for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high, or waived complexity tests.This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
